Page 24 - 74_01

MERITXELL NUS Y COLS. AN. R. ACAD. NAC. FARM.

(24) FUHRMAN, B.; VOLKOVA, N. and AVIRAM, M. (2002): Oxidative stress increases
(25) the expression of the CD36 scavenger receptor and the cellular uptake of
(26) oxidized LDL in macrophages from atherosclerotic mice: protective role of
(27) antioxidants and of paraoxonase. Atherosclerosis. 161: 307-316.
(28) ROZENBERG, O.; SHIH, D. M. and AVIRAM, M. (2003): Human serum paraoxona-
(29) se (PON1) decreases macrophage cholesterol biosynthesis: a possible role for
(30) its phospholipase-A2 activity and lysophosphatidylcholine formation. Arte-
(31) rioscler. Thromb. Vasc. Biol. 23: 461-467.
(32) ROSENBLAT, M.; VAYA, J.; SHIH, D. M. and AVIRAM, M. (2005): Paraoxonase 1
(33) (PON1) enhances HDL-mediated macrophage cholesterol efflux via the
(34) ABCA1 transporter in association with increased HDL binding to the cells: a
(35) possible role for lysophosphatidylcoline. Atherosclerosis. 179: 69-77.
(36) MACKNESS, B.; DURRINGTON, P. N.; MCELDUFF, P., et al. (2003): Low paraoxonase
activity predicts coronary events in the Caerphilly prospective. Circulation.
107: 2775-2779.
TOMÁS, M.; SENTÍ, M.; GARCÍA-FARIA, F.; VILA, J.; TORRENTS, A.; COVAS, M. and
MARRUGAT, J. (2000): Effect of simvastatin therapy on paraoxonase activity
and related lipoproteins in familial hypercholesterolemic patients. Arterios-
cler. Thromb. Vasc. Biol. 20: 2113-2119.
ABBOTT, C. A.; MACKNESS, M. I.; KUMAR, S., et al. (1995): Serum paraoxonase
activity, concentration, and phenotype distribution in diabetes mellitus and
its relationship to serum lipids and lipoproteins. Arterioscler. Thromb. Vasc.
Biol. 15: 1812-1818.
SUTHERLAND, W. H. F.; MANNING, P. J.; DE JONG, S. A.; ALLUM, A. R.; JONES, S.
D. and WILLIAMS, S. M. (2001): Hormone-replacement therapy increases serum
paraoxonase/arylesterase activity in diabetic postmenopausal women. Meta-
bolism. 50: 319-324.
FERRÉ, N.; CAMPS, J.; PRATS, E.; VILELLA, E.; PAUL, A.; FIGUERA, L. and JOVEN, J.
(2002): Serum paraoxonase activity: a new additional test for the improved
evaluation of chronic liver damage. Clin. Chem. 48: 261-268.
SUTHERLAND, W. H. F.; DE JONG, S. A. and WALKER, R. J. (2004): Hypochlorous
acid and low serum paraoxonase activity in haemodialysis patients: an in
vitro study. Nephrol. Dial. Transplant. 19: 75-82.
SARANDOL, E.; SERDAR, Z.; DIRICAN, M. and SAVAK, O. (2003): Effects of red wine
consumption on serum paraoxonase/arylesterasa activities and on lipopro-
tein oxidizability in healthy-men. J. Nutr. Biochem. 14: 507-512.
WALLACE, A. J.; SUTHERLAND, W. H. F.; MANN, J. I. and WILLIAMS; S. M. (2001):
The effect of meals rich in thermally stressed olive and safflower oils on
postprandial serum paraoxonase activity in patients with diabetes. Eur. J.
Clin. Nutr. 55: 951-958.
LEVIEV, I. and JAMES, R. W. (2000): Promoter polymorphisms of human pa-
raoxonase PON1 gene and serum paraoxonase activities and concentrations.
Arterioscler. Thromb. Vasc. Biol. 20: 516-521.
JAMES, R. W.; LEVIEV, I.; RUIZ, J.; PASSA, P.; FROGUEL, P. and GARIN, M. C.
(2000): Promoter polymorphism T(-107)C of the paraoxonase PON1 gene is

26